{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:38:54Z","timestamp":1794051534885,"version":"4.8.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1\u2013ST17) have been identified, 9 of which have been isolated from humans. Differences in clinical consequences may depend on differences among the STs. Here, we evaluated the prevalence of\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      sp. in patients with colorectal cancer (CRC) compared to a control group and assessed the relationships between\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      sp. infection and sex; age; and CRC grade, stage, and location.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study included 107 CRC patients (41 women and 66 men, median age 65\u00a0years); 124 subjects without colorectal cancer or a history of oncological disease comprised the control group (55 women and 69 men, median age 63). Stool samples were collected from patients before oncological treatment and examined using light microscopy (iodine-stained smear). Additionally, PCR-based identification of\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      sp. was performed in 95 stool samples from CRC patients and 76 stool samples from the control group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Light microscopy showed that the prevalence of\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      sp. was significantly higher in CRC patients than in the control group (12.15% and 2.42%, respectively;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0041). Multivariate analysis showed that the odds of\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      sp. infection were fivefold higher in the CRC group than in the control group. PCR-based molecular examinations demonstrated that the proportion of patients infected with\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      sp. was significantly higher in the CRC group than in the control group (12.63% and 2.63%, respectively;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.023). The predominant ST in the CRC group was ST3, detected in nine patients (75%), followed by ST1 (2 patients, 16.7%) and ST2 (1 patient, 8.3%). No association was found between\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      sp. infection and age, sex, or CRC stage, grade, or location.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The results showed that CRC was associated with an increased risk of opportunistic\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      sp. infection, even before oncological treatment. To the best of our knowledge, this is the first report estimating the prevalence of\n                      <jats:italic>Blastocystis<\/jats:italic>\n                      sp. infection in CRC patients before oncological treatment in Europe.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-021-04681-x","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T16:34:50Z","timestamp":1618418090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Colorectal cancer and Blastocystis sp. infection"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7542-1414","authenticated-orcid":false,"given":"Violetta","family":"Sul\u017cyc-Bielicka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Ko\u0142odziejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Adamska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogumi\u0142a","family":"Skotarczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Jaczewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Safranow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Bielicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3zef","family":"K\u0142adny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Bielicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"key":"4681_CR1","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1002\/ijc.21731","volume":"118","author":"DM Parkin","year":"2006","unstructured":"Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030\u201344.","journal-title":"Int J Cancer"},{"key":"4681_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJM200007133430201","volume":"343","author":"P Lichtenstein","year":"2000","unstructured":"Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343:78\u201385.","journal-title":"N Engl J Med"},{"key":"4681_CR3","doi-asserted-by":"publisher","first-page":"766","DOI":"10.15252\/msb.20145645","volume":"10","author":"G Zeller","year":"2014","unstructured":"Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol. 2014;10:766.","journal-title":"Mol Syst Biol."},{"key":"4681_CR4","first-page":"101","volume":"11","author":"S Jahani-Sherafat","year":"2018","unstructured":"Jahani-Sherafat S, Alebouyeh M, Moghim Sh, Ahmadi-Amoli H, Ghasemian Safaei H. Role of gut microbiota in the pathogenesis of colorectal cancer; a review article. Gastroenterol Hepatol Bed Bench. 2018;11:101\u20139.","journal-title":"Gastroenterol Hepatol Bed Bench."},{"key":"4681_CR5","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1017\/S0031182013000255","volume":"140","author":"MA Alfellani","year":"2013","unstructured":"Alfellani MA, Jacob AS, Perea NO, Krecek RC, Taner-Mulla D, Verweij JJ, et al. Diversity and distribution of Blastocystis sp. subtypes in non-human primates. Parasitology. 2013;140:966\u201371.","journal-title":"Parasitology."},{"key":"4681_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mcp.2007.06.007","volume":"22","author":"PG Menounos","year":"2008","unstructured":"Menounos PG, Spanakos G, Tegos N, Vassalos CM, Papadopoulou C, Vakalis NC. Direct detection of Blastocystis sp. in human faecal samples and subtype assignment using single strand conformational polymorphism and sequencing. Mol Cell Probes. 2008;22:24\u20139.","journal-title":"Mol Cell Probes."},{"key":"4681_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.vetpar.2004.09.017","volume":"126","author":"KS Tan","year":"2004","unstructured":"Tan KS. Blastocystis in humans and animals: new insights using modern methodologies. Vet Parasitol. 2004;126:121\u201344.","journal-title":"Vet Parasitol"},{"key":"4681_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.4269\/ajtmh.2008.79.401","volume":"79","author":"S Leelayoova","year":"2008","unstructured":"Leelayoova S, Siripattanapipong S, Thathaisong U, Naaglor T, Taamasri P, Piyaraj P, Mungthin M. Drinking water: a possible source of Blastocystis spp. subtype 1 infection in schoolchildren of a rural community in central Thailand. Am J Trop Med Hyg. 2008;79:401\u20136.","journal-title":"Am J Trop Med Hyg."},{"key":"4681_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.meegid.2013.07.020","volume":"22","author":"JD Ramirez","year":"2014","unstructured":"Ramirez JD, S\u00e1nchez LV, Bautista DC, Corredor AF, Fl\u00f3rez AC, Stensvold CR. Blastocystis subtypes detected in humans and animals from Colombia. Infect Genet Evol. 2014;22:223\u20138.","journal-title":"Infect Genet Evol."},{"key":"4681_CR10","doi-asserted-by":"publisher","first-page":"588","DOI":"10.4269\/ajtmh.2009.80.588","volume":"80","author":"BA Rene","year":"2009","unstructured":"Rene BA, Stensvold CR, Badsberg JH, Nielsen HV. Subtype analysis of Blastocystis isolates from Blastocystis cyst excreting patients. Am J Trop Med Hyg. 2009;80:588\u201392.","journal-title":"Am J Trop Med Hyg"},{"key":"4681_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002545","volume":"8","author":"P Poirier","year":"2012","unstructured":"Poirier P, Wawrzyniak I, Vivar\u00e8s CP, Delbac F, El Alaoui H. New insights into Blastocystis spp.: a potential link with irritable bowel syndrome. PLoS Pathog. 2012;8:","journal-title":"PLoS Pathog"},{"issue":"507\u201313","key":"4681_CR12","volume":"13","author":"LR Krogsgaard","year":"2015","unstructured":"Krogsgaard LR, Engsbro AL, Stensvold CR, Nielsen HV, Bytzer P. The prevalence of intestinal parasites is not greater among individuals with irritable bowel syndrome: a Population-based Case-control Study. Clin Gastroenterol Hepatol. 2015;13(507\u201313):","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4681_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/1574-6941.12396","volume":"90","author":"PD Scanlan","year":"2014","unstructured":"Scanlan PD, Stensvold CR, Rajili\u0107-Stojanovi\u0107 M, Heilig HG, De Vos WM, O\u2019Toole PW, Cotter PD. The microbial eukaryote Blastocystis is a prevalent and diverse member of the healthy human gut microbiota. FEMS Microbiol Ecol. 2014;90:326\u201330.","journal-title":"FEMS Microbiol Ecol"},{"key":"4681_CR14","doi-asserted-by":"publisher","first-page":"2848","DOI":"10.1038\/ismej.2017.139","volume":"11","author":"F Beghini","year":"2017","unstructured":"Beghini F, Pasolli E, Truong TD, Putignani L, Cacci\u00f2 SM, Segata N. Large-scale comparative metagenomics of Blastocystis, a common member of the human gut microbiome. ISME J. 2017;11:2848\u201363.","journal-title":"ISME J"},{"key":"4681_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.trstmh.2011.12.008","volume":"106","author":"S Chandramathi","year":"2012","unstructured":"Chandramathi S, Suresh K, Anita ZB, Kuppusamy UR. Infections of Blastocystis hominis and microsporidia in cancer patients: are they opportunistic? Trans R Soc Trop Med Hyg. 2012;106:267\u20139.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"4681_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pt.2007.01.004","volume":"23","author":"CR Stensvold","year":"2007","unstructured":"Stensvold CR, Suresh GK, Tan KS, Thompson RC, Traub RJ, Viscogliosi E, Yoshikawa H, Clark CG. Terminology for Blastocystis subtypes \u2013 a consensus. Trends Parasitol. 2007;23:93\u20136.","journal-title":"Trends Parasitol."},{"key":"4681_CR17","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1128\/JCM.43.1.348-355.2005","volume":"43","author":"C Noel","year":"2005","unstructured":"Noel C, Dufernez F, Gerbod D, Edgcomb VP, Delgado-Viscogliosi P, Ho LC. Molecular phylogenies of Blastocystis isolates from different hosts: implications for genetic diversity, identification of species, and zoonosis. J Clin Microbiol. 2005;43:348\u201355.","journal-title":"J Clin Microbiol"},{"key":"4681_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/2229-5070.113896","volume":"3","author":"CR Stensvold","year":"2013","unstructured":"Stensvold CR. Blastocystis: genetic diversity and molecular methods for diagnosis and epidemiology. Trop Parasitol. 2013;3:26\u201334.","journal-title":"Trop Parasitol."},{"key":"4681_CR19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.parint.2016.05.015","volume":"65","author":"CR Stensvold","year":"2016","unstructured":"Stensvold CR, Clark CG. Current status of Blastocystis: a personal view. Parasitol Int. 2016;65:763\u201371.","journal-title":"Parasitol Int"},{"key":"4681_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jiph.2017.03.009","volume":"11","author":"S Khademvatan","year":"2018","unstructured":"Khademvatan S, Masjedizadeh R, Yousefi-Razin E, Mahbodfar H, Rahim F, Yousefi E, Foroutan M. PCR-based molecular characterization of Blastocystis hominis subtypes in southwest of Iran. J Infect Public Health. 2018;11:43\u20137.","journal-title":"J Infect Public Health."},{"key":"4681_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.parint.2017.01.005","volume":"66","author":"S Khademvatan","year":"2017","unstructured":"Khademvatan S, Masjedizadeh R, Rahim F, Mahbodfar H, Salehi R, Yousefi-Razin E, Foroutan M. Blastocystis and irritable bowel syndrome: frequency and subtypes from Iranian patients. Parasitol Int. 2017;66:142\u20135.","journal-title":"Parasitol Int"},{"key":"4681_CR22","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.parint.2016.05.007","volume":"65","author":"SSR Ajjampur","year":"2016","unstructured":"Ajjampur SSR, Tan KSW. Pathogenic mechanisms in Blastocystis spp. \u2013 Interpreting results from in vitro and in vivo studies. Parasitol Int. 2016;65:772\u20139.","journal-title":"Parasitol Int."},{"key":"4681_CR23","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1128\/JCM.02520-15","volume":"54","author":"LO Andersen","year":"2016","unstructured":"Andersen LO, Stensvold C. Blastocystis in health and disease: are we moving from a clinical to a public health perspective? J Clin Microbiol. 2016;54:524\u20138.","journal-title":"J Clin Microbiol"},{"key":"4681_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00436-008-1031-3","volume":"103","author":"F Dogruman-Al","year":"2008","unstructured":"Dogruman-Al F, Dagci H, Yoshikawa H, Kurt O, Demirel M. A possible link between subtype 2 and asymptomatic infections of Blastocystis hominis. Parasitol Res. 2008;103:685\u20139.","journal-title":"Parasitol Res"},{"key":"4681_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00436-008-1163-5","volume":"104","author":"TC Tan","year":"2008","unstructured":"Tan TC, Suresh KG, Smith HV. Phenotypic and genotypic characterisation of Blastocystis hominis isolates implicates subtype 3 as a subtype with pathogenic potential. Parasitol Res. 2008;104:85\u201393.","journal-title":"Parasitol Res"},{"key":"4681_CR26","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00436-007-0808-0","volume":"102","author":"KH Wong","year":"2008","unstructured":"Wong KH, Ng GC, Lin RT, Yoshikawa H, Taylor MB, Tan KS. Predominance of subtype 3 among Blastocystis isolates from a major hospital in Singapore. Parasitol Res. 2008;102:663\u201370.","journal-title":"Parasitol Res"},{"key":"4681_CR27","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00436-007-0833-z","volume":"102","author":"EM Hussein","year":"2008","unstructured":"Hussein EM, Hussein AM, Eida MM, Atwa MM. Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. Parasitol Res. 2008;102:853\u201360.","journal-title":"Parasitol Res"},{"key":"4681_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.parint.2008.01.004","volume":"57","author":"M Ozyurt","year":"2008","unstructured":"Ozyurt M, Kurt O, M\u00f8lbak K, Nielsen HV, Haznedaroglu T, Stensvold CR. Molecular epidemiology of Blastocystis infections in Turkey. Parasitol Int. 2008;57:300\u20136.","journal-title":"Parasitol Int"},{"key":"4681_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00436-008-1198-7","volume":"104","author":"MS Jones","year":"2009","unstructured":"Jones MS, Whipps CM, Ganac RD, Hudson NR, Boorom K. Association of Blastocystis subtype 3 and 1 with patients from an Oregon community presenting with chronic gastrointestinal illness. Parasitol Res. 2009;104:341\u20135.","journal-title":"Parasitol Res"},{"key":"4681_CR30","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1007\/s00436-012-3085-5","volume":"111","author":"A Moosavi","year":"2012","unstructured":"Moosavi A, Haghighi A, Mojarad EN, Zayeri F, Alebouyeh M, Khazan H, Kazemi B, Zali MR. Genetic variability of Blastocystis sp. isolated from symptomatic and asymptomatic individuals in Iran. Parasitol Res. 2012;111:2311\u20135.","journal-title":"Parasitol Res."},{"key":"4681_CR31","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12879-016-1776-8","volume":"16","author":"D ElSafadi","year":"2016","unstructured":"ElSafadi D, Cian A, Nourrisson C, Pereira B, Morelle C, Bastien P, et al. Prevalence, risk factors for infection and subtype distribution of the intestinal parasite Blastocystis sp. from a large-scale multi-center study in France. BMC Infect Dis. 2016;16:451.","journal-title":"BMC Infect Dis."},{"key":"4681_CR32","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1128\/JCM.38.4.1324-1330.2000","volume":"38","author":"H Yoshikawa","year":"2000","unstructured":"Yoshikawa H, Abe N, Iwasawa M, Kitano S, Nagano I, Wu Z, Takahashi Y. Genomic analysis of Blastocystis hominis strains isolated from two long-term health care facilities. J Clin Microbiol. 2000;38:1324\u201330.","journal-title":"J Clin Microbiol"},{"key":"4681_CR33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1046\/j.1365-3156.1997.d01-383.x","volume":"2","author":"B B\u00f6hm-Gloning","year":"1997","unstructured":"B\u00f6hm-Gloning B, Knobloch J, Walderich B. Five subgroups of Blastocystis hominis isolates from symptomatic and asymptomatic patients revealed by restriction site analysis of PCR-amplified 16S-like rDNA. Trop Med Int Health. 1997;2:771\u20138.","journal-title":"Trop Med Int Health."},{"key":"4681_CR34","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2013","unstructured":"Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 60. Mol Biol Evol. 2013;28:2731\u20139.","journal-title":"Mol Biol Evol."},{"key":"4681_CR35","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1101\/gr.126516.111","volume":"22","author":"M Castellarin","year":"2012","unstructured":"Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22:299\u2013306.","journal-title":"Genome Res"},{"key":"4681_CR36","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1038\/ncomms7528","volume":"6","author":"Q Feng","year":"2015","unstructured":"Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun. 2015;6:6528.","journal-title":"Nat Commun."},{"key":"4681_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/gutjnl-2015-309800","volume":"66","author":"J Yu","year":"2017","unstructured":"Yu J, Feng Q, Wong SH, Zhang D, Liang Q, Qin Y, Tang L, Zhao H, Stenvang J, Li Y, Wang X. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. 2017;66:70\u20138.","journal-title":"Gut"},{"key":"4681_CR38","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41591-019-0405-7","volume":"25","author":"AM Thomas","year":"2019","unstructured":"Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med. 2019;25:667\u201378.","journal-title":"Nat Med"},{"key":"4681_CR39","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","volume":"25","author":"J Wirbel","year":"2019","unstructured":"Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25:679\u201389.","journal-title":"Nat Med"},{"key":"4681_CR40","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","volume":"16","author":"SH Wong","year":"2019","unstructured":"Wong SH, Yu J. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications. Nat Rev Gastroenterol Hepatol. 2019;16:690\u2013704.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"4681_CR41","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1136\/gutjnl-2018-317178","volume":"68","author":"OO Coker","year":"2019","unstructured":"Coker OO, Nakatsu G, Dai RZ, Wu WKK, Wong SH, Ng SC, et al. Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer. Gut. 2019;68:654\u201362.","journal-title":"Gut"},{"key":"4681_CR42","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.ccell.2018.03.004","volume":"33","author":"H Tilg","year":"2018","unstructured":"Tilg H, Adolph TE, Gerner RR, Moschen AR. The intestinal microbiota in colorectal cancer. Cancer Cell. 2018;33:954\u201364.","journal-title":"Cancer Cell"},{"key":"4681_CR43","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1158\/0008-5472.CAN-16-3472","volume":"77","author":"S Tomkovich","year":"2017","unstructured":"Tomkovich S, Yang Y, Winglee K, Gauthier J, M\u00fchlbauer M, Sun X, et al. Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis. Cancer Res. 2017;77:2620\u201332.","journal-title":"Cancer Res"},{"key":"4681_CR44","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrmicro3344","volume":"12","author":"P Louis","year":"2014","unstructured":"Louis P, Hold GL, Flint HJ. The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol. 2014;12:661\u201372.","journal-title":"Nat Rev Microbiol"},{"key":"4681_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1136\/gutjnl-2018-317200","volume":"68","author":"Z He","year":"2019","unstructured":"He Z, Gharaibeh RZ, Newsome RC, Pope JL, Dougherty MW, Tomkovich S, et al. Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin. Gut. 2019;68:289\u2013300.","journal-title":"Gut"},{"key":"4681_CR46","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/gutjnl-2014-307241","volume":"65","author":"A Cougnoux","year":"2016","unstructured":"Cougnoux A, Delmas J, Gibold L, Fa\u00efs T, Romagnoli Ch, Robin F, et al. Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria. Gut. 2016;65:278\u201385.","journal-title":"Gut"},{"key":"4681_CR47","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrmicro2819","volume":"10","author":"H Tjalsma","year":"2012","unstructured":"Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012;10:575\u201382.","journal-title":"Nat Rev Microbiol"},{"key":"4681_CR48","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","volume":"146","author":"AD Kostic","year":"2014","unstructured":"Kostic AD, Xavier RJ, Gevers D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology. 2014;146:1489\u201399.","journal-title":"Gastroenterology"},{"key":"4681_CR49","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature13828","volume":"517","author":"CG Buffie","year":"2015","unstructured":"Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature. 2015;517:205\u20138.","journal-title":"Nature"},{"key":"4681_CR50","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/gutjnl-2016-313235","volume":"66","author":"V Pascal","year":"2017","unstructured":"Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, et al. A microbial signature for Crohn\u2019s disease. Gut. 2017;66:813\u201322.","journal-title":"Gut"},{"key":"4681_CR51","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/gutjnl-2013-304833","volume":"63","author":"K Machiels","year":"2014","unstructured":"Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. 2014;63:1275\u201383.","journal-title":"Gut"},{"key":"4681_CR52","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3748\/wjg.v20.i5.1192","volume":"20","author":"GL Hold","year":"2014","unstructured":"Hold GL, Smith M, Grange C, Watt ER, El-Omar EM, Mukhopad-hya I. Role of the gut microbiota in inflammatory bowel disease pathogenesis: What have we learnt in the past 10\u00a0years? World J Gastroenterol. 2014;20:1192\u2013210.","journal-title":"World J Gastroenterol"},{"key":"4681_CR53","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1080\/00365521.2016.1216587","volume":"51","author":"M Prosberg","year":"2016","unstructured":"Prosberg M, Bendtsen F, Vind I, Petersen AM, Gluud LL. The association between the\u00a0gut\u00a0microbiota\u00a0and the inflammatory bowel disease activity: a systematic review and\u00a0meta-analysis. Scand J Gastroenterol. 2016;51:1407\u201315.","journal-title":"Scand J Gastroenterol"},{"key":"4681_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.606298","volume":"7","author":"J Sankarasubramanian","year":"2020","unstructured":"Sankarasubramanian J, Ahmad R, Avuthu N, Singh AB, Guda C. Gut\u00a0microbiota\u00a0and metabolic specificity in ulcerative colitis and Crohn\u2019s disease. Front Med. 2020;7:","journal-title":"Front Med"},{"key":"4681_CR55","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.arcmed.2017.11.015","volume":"48","author":"O Partida-Rodr\u00edguez","year":"2017","unstructured":"Partida-Rodr\u00edguez O, Serrano-V\u00e1zquez A, Nieves-Ram\u00edrez ME, Moran P, Rojas L, Portillo T, et al. Human intestinal microbiota: interaction between parasites and the host immune response. Arch Med Res. 2017;48:690\u2013700.","journal-title":"Arch Med Res"},{"key":"4681_CR56","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.2174\/1381612824666180807101536","volume":"24","author":"V Kumarasamy","year":"2018","unstructured":"Kumarasamy V, Anbazhagan D, Subramaniyan V, Vellasamy S. Blastocystis sp., Parasite Associated with Gastrointestinal Disorders: An Overview of its Pathogenesis, Immune Modulation and Therapeutic Strategies. Curr Pharm Des. 2018;24:3172\u20135.","journal-title":"Curr Pharm Des."},{"key":"4681_CR57","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.pt.2018.02.004","volume":"34","author":"CR Stensvold","year":"2018","unstructured":"Stensvold CR, van der Giezen M. Associations between Gut Microbiota and Common Luminal Intestinal Parasites. Trends Parasitol. 2018;34:369\u201377.","journal-title":"Trends Parasitol."},{"key":"4681_CR58","first-page":"40","volume":"30","author":"M K\u00f6k","year":"2019","unstructured":"K\u00f6k M, \u00c7ekin Y, \u00c7ekin AH, Uyar S, Harmandar F, \u015eahint\u00fcrk Y. The role of Blastocystis hominis in the activation of ulcerative colitis. Turk J Gastroenterol. 2019;30:40\u20136.","journal-title":"Turk J Gastroenterol."},{"key":"4681_CR59","doi-asserted-by":"publisher","first-page":"489","DOI":"10.15403\/jgld.2014.1121.254.yiz","volume":"25","author":"S Yildiz","year":"2016","unstructured":"Yildiz S, Do\u011fan \u0130, Do\u011fruman-Al F, Nalbanto\u011flu U, \u00dcstek D, Sarzhanov F, Yildirim S. Association of Enteric Protist Blastocystis spp and Gut Microbiota with Hepatic Encephalopathy. J Gastrointestin Liver Dis. 2016;25:489\u201397.","journal-title":"J Gastrointestin Liver Dis."},{"key":"4681_CR60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3109\/00365548.2013.861609","volume":"46","author":"AL Engsbro","year":"2014","unstructured":"Engsbro AL, Stensvold CR, Vedel Nielsen H, Bytzer P. Prevalence, incidence, and risk factors of intestinal parasites in Danish primary care patients with irritable bowel syndrome. Scand J Infect Dis. 2014;46:204\u20139.","journal-title":"Scand J Infect Dis"},{"key":"4681_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111868","volume":"9","author":"C Nourrisson","year":"2014","unstructured":"Nourrisson C, Scanzi J, Pereira B, et al. Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS ONE. 2014;9:","journal-title":"PLoS ONE"},{"key":"4681_CR62","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.8179","volume":"10","author":"V Iebba","year":"2016","unstructured":"Iebba V, Santangelo F, Totino V, Pantanella F, Monsia A, DiCristanziano V, et al. Gut microbiota related to Giardia duodenalis, Entamoeba spp and Blastocystis hominis infections in humans from Cote d\u2019Ivoire. J Infect Dev Ctries. 2016;10:","journal-title":"J Infect Dev Ctries."},{"key":"4681_CR63","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fcimb.2012.00141","volume":"2","author":"F Berrilli","year":"2012","unstructured":"Berrilli F, Di Cave D, Cavallero S, Cavallero S, D\u2019Amelio S. Interactions between parasites and microbial communities in the human gut. Front Cell Infect Microbiol. 2012;2:141.","journal-title":"Front Cell Infect Microbiol."},{"key":"4681_CR64","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1007\/s00436-018-6070-9","volume":"117","author":"A Toychiev","year":"2018","unstructured":"Toychiev A, Abdujapparov S, Imamov A, Navruzov B, Davis N, Badalova N, Osipova S. Intestinal helminths and protozoan infections in patients with colorectal cancer: prevalence and possible association with cancer pathogenesis. Parasitol Res. 2018;117:3715\u201323.","journal-title":"Parasitol Res"},{"key":"4681_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13027-017-0131-z","volume":"12","author":"AM Mohamed","year":"2017","unstructured":"Mohamed AM, Ahmed MA, Ahmed SA, Al-Semany SA, Alghamdi SS, Zaglool DA. Predominance and association risk of Blastocystis hominis subtype I in colorectal cancer: a case control study. Infect Agent Cancer. 2017;12:21.","journal-title":"Infect Agent Cancer."},{"key":"4681_CR66","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.parint.2016.02.010","volume":"65","author":"O Yersal","year":"2016","unstructured":"Yersal O, Malatyali E, Ertabaklar H, Oktay E, Barutca S, Ertug S. Blastocystis subtypes in cancer patients: analysis of possible risk factors and clinical characteristics. Parasitol Int. 2016;65:792\u20136.","journal-title":"Parasitol Int"},{"key":"4681_CR67","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1756-3305-7-162","volume":"7","author":"V Kumarasamy","year":"2014","unstructured":"Kumarasamy V, Roslani AC, Rani KU, Kumar Govind S. Advantage of using colonic washouts for Blastocystis detection in colorectal cancer patients. Parasit Vectors. 2014;7:162.","journal-title":"Parasit Vectors."},{"key":"4681_CR68","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00436-010-1764-7","volume":"106","author":"S Chandramathi","year":"2010","unstructured":"Chandramathi S, Suresh K, Kuppusamy UR. Solubilized antigen of Blastocystis hominis facilitates the growth of human colorectal cancer cells, HCT116. Parasitol Res. 2010;106:941\u20135.","journal-title":"Parasitol Res"},{"key":"4681_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183097","volume":"12","author":"V Kumarasamy","year":"2017","unstructured":"Kumarasamy V, Kuppusamy UR, Jayalakshmi P, Samudi C, Ragavan ND, Kumar S. Exacerbation of colon carcinogenesis by Blastocystis sp. PLoS ONE. 2017;12:","journal-title":"PLoS ONE"},{"key":"4681_CR70","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1007\/s00436-011-2788-3","volume":"110","author":"KH Chan","year":"2012","unstructured":"Chan KH, Chandramathi S, Suresh K, Chua KH, Kuppusamy UR. Effects of symptomatic and asymptomatic isolates of Blastocystis hominis on colorectal cancer cell line, HCT116. Parasitol Res. 2012;110:2475\u201380.","journal-title":"Parasitol Res"},{"key":"4681_CR71","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1007\/s00436-013-3538-5","volume":"112","author":"V Kumarasamy","year":"2013","unstructured":"Kumarasamy V, Kuppusamy UR, Samudi C, Kumar S. Blastocystis sp. subtype 3 triggers higher proliferation of human colorectal cancer cells, HCT116. Parasitol Res. 2013;112:3551\u20135.","journal-title":"Parasitol Res."},{"key":"4681_CR72","first-page":"122","volume":"7","author":"S Padukone","year":"2017","unstructured":"Padukone S, Mandal J, Parija SC. Severe Blastocystis subtype 3 infection in a patient with colorectal cancer. Trop Parasitol. 2017;7:122\u20134.","journal-title":"Trop Parasitol."},{"key":"4681_CR73","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/ni.3384","volume":"17","author":"A Lasry","year":"2016","unstructured":"Lasry A, Zinger A, Ben-Neriah Y. Inflammatory networks underlying colorectal cancer. Nat Immunol. 2016;17:230\u201340.","journal-title":"Nat Immunol"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-021-04681-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-021-04681-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-021-04681-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T16:42:45Z","timestamp":1618418565000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-021-04681-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4681"],"URL":"https:\/\/doi.org\/10.1186\/s13071-021-04681-x","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"assertion":[{"value":"15 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were reviewed and approved by the Bioethics Committee of Pomeranian Medical University (No. KB-0012\/238\/06\/18). According to the Bioethics Committee instructions, verbal consent was obtained from patients because of non-invasive nature of the conducted study. Examinations were performed in addition to routine stool sample investigations for parasite infection. Attestation statements of verbal consent of all participants in the conducted study signed by the physicians were documented in medical records.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}